Miriam Komaromy, MD
Boston University School of Medicine
Dept of Medicine
General Internal Medicine

MD, University of California, San Francisco

Miriam Komaromy, MD is the Medical Director of the Grayken Center for Addiction at Boston Medical Center, and a Professor in the Division of General Internal Medicine, Department of Medicine, Boston University School of Medicine. In her role at the Grayken Center she leads programs focused on expanding access to care and engagement with care for patients who have substance use disorders, particularly those from marginalized patient populations. Other areas of focus within the Grayken Center include:
--Development of a new Grayken Addiction Nursing Fellowship and support for the Grayken Addiction Medicine Fellowships
--Leadership on adaptation of SUD treatment during the COVID pandemic, including BMC's COVID Recuperation Unit for people who are COVID-infected and experiencing homelessness
--Research focused on care of young adults with substance use disorder and on care of BIPOC populations
--Policy and Advocacy focused on workforce development, harm reduction, HIV prevention, and overdose prevention in newly housed individuals

Komaromy is also PI of a NIMH-funded clinical trial (along with mPI Dr. Kate Watkins of RAND corporation) that is evaluating the impact of the Collaborative Care model on outcomes of care for people who have co-occurring opioid use disorder plus PTSD or depression in 13 primary care clinics in New Mexico.

Prior to her role at BMC, Komaromy led the Extension for Healthcare Outcomes (ECHO) Institute’s programs for addiction and psychiatry. She has also served on the American Society of Addiction Medicine’s (ASAM’s) National Board of Directors (2017-2021) and served as medical director for a state addiction treatment hospital in New Mexico and for Albuquerque Health Care for the Homeless.

Komaromy recently partnered with the American Society of Addiction Medicine to launch an ECHO hub to educate health care professionals around the country on the treatment of substance use disorders. She also led the federally-funded program that developed and launched five national ECHO hubs focused on treatment of opioid use disorder (including one based in BMC's OBAT program), after developing the nation’s first addiction-focused ECHO program.

Komaromy was previously a professor in the Department of Internal Medicine at the University of New Mexico. She received her medical degree from the University of California, San Francisco and completed her residency in internal medicine at UCSF/San Francisco General Hospital. She was a Robert Wood Johnson Clinical Scholar at the UCSF/Stanford program. She joined the UCSF faculty of Medicine after her training, and served as the residency director for the UCSF Primary Care Internal Medicine Residency program at San Francisco General Hospital. She is board certified in Addiction Medicine by the American Board of Preventive Medicine.

Komaromy’s research has focused on health disparities and care for traditionally underserved populations; models of post-graduate medical education; and care for patients with substance use disorders and complex health conditions. In 2018, Komaromy received a Fulbright Scholar award from the US State Department, teaching about substance use disorders and medical education in Vietnam, Thailand, and Indonesia and studying treatment of opioid use disorder in Vietnam. She is the vice-chair of the ASAM National Medical Education Committee. In 2019 she received ASAM's Educator of the Year award.

2019 Psychiatric Services Journal: Editor's Choice Award
2019 ASAM: Educator of the Year
2018 US State Department: Fulbright Scholar, Hanoi Vietnam
2018 ASAM: Awarded “Distinguished Fellow”
2016 Association for Medical Education and Research in Substance Abuse: Best program/ Curriculum Abstract
2016 Substance Abuse Journal: Article of the Year Award
2014 Physician Support Service: National Mentor for Medication Assisted Treatment
2013 American College of Physicians: Fellow
2010 Bernalillo County Commission: Exceptional Public Service Award
2008 Physician Support Service: National Mentor for Buprenorphine Treatment
1996 Association of Health Services Research: Article of the Year Award
1990 UCSF: Outstanding Intern of the Year Award
1989 UCSF: Alpha Omega Alpha

Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness
09/12/2019 - 09/30/2021 (PI)
RAND Corporation NIH-NIMH

COVID Recuperation Unit White Paper - NoA issued 07/22/20-
08/03/2020 - 10/23/2020 (PI)
RIZE Massachusetts


Grant to develop curriculum focused on substance use disorders
09/01/2019 - 09/01/2021 (PI)

Grant to develop a white paper on how to develop and implement a medical recuperation facility for COVID-infected people experiencing homelessness.
07/10/2020- (PI)
RIZE Massachusetts

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Harris MTH, Young S, Barocas J, Bayoumi AM, Caudarella A, Laurence G, Tomanovich M, Komaromy M. A Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for People Experiencing Homelessness During the COVID-19 Pandemic, Boston and Toronto. Public Health Rep. 2021 Sep-Oct; 136(5):532-537.View Related Profiles. PMID: 34269625; PMCID: PMC8361564; DOI: 10.1177/00333549211032974;
  2. Meredith LS, Komaromy MS, Cefalu M, Murray-Krezan C, Page K, Osilla KC, Dopp AR, Leamon I, Tarhuni L, Hindmarch G, Jacobsohn V, Watkins KE. Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder. Contemp Clin Trials. 2021 05; 104:106354. PMID: 33713840; PMCID: PMC8432760; DOI: 10.1016/j.cct.2021.106354;
  3. Barocas JA, Gai MJ, White LF, Faretra D, Sachs K, Komaromy M. Implementation of a Recuperation Unit and Hospitalization Rates Among People Experiencing Homelessness With COVID-19. JAMA Netw Open. 2021 03 01; 4(3):e212826.View Related Profiles. PMID: 33688963; PMCID: PMC7948053; DOI: 10.1001/jamanetworkopen.2021.2826;
  4. Komaromy M, Harris M, Koenig RM, Tomanovich M, Ruiz-Mercado G, Barocas JA. Caring for COVID's Most Vulnerable Victims: a Safety-Net Hospital Responds. J Gen Intern Med. 2021 04; 36(4):1006-1010.View Related Profiles. PMID: 33469746; PMCID: PMC7815181; DOI: 10.1007/s11606-020-06499-2;
  5. Komaromy M, Mendez-Escobar E, Madden E. Addressing Racial Trauma in the Treatment of Substance Use Disorders. Pediatrics. 2021 01; 147(Suppl 2):S268-S270. PMID: 33386331
  6. Komaromy M, Tomanovich M, Taylor JL, Ruiz-Mercado G, Kimmel SD, Bagley SM, Saia KM, Costello E, Park TW, LaBelle C, Weinstein Z, Walley AY. Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic. J Addict Med. 2020 Dec 08.View Related Profiles. PMID: 33298750
  7. Komaromy M, Harris, Koenig MRM, Tomanovich MM, Ruiz-Mercado G, Barocas JA. Caring for COVID's most vulnerable victims: a safety-net hospital responds. Res Sq. 2020 Oct 26.View Related Profiles. PMID: 33140040; PMCID: PMC7605557; DOI: 10.21203/rs.3.rs-97328/v1;
  8. Barocas JA, Komaromy M, Haidar D, Barlam TF, Orr BL, Miller NS. Assessment of Oropharyngeal Specimens for Discontinuation of Transmission-Based COVID-19 Precautions. Open Forum Infect Dis. 2020 Sep; 7(9):ofaa382.View Related Profiles. PMID: 32964067; PMCID: PMC7494181; DOI: 10.1093/ofid/ofaa382;
  9. Mahadevan J, Shukla L, Chand PK, Komaromy M, Murthy P, Arora S. Innovative virtual mentoring using the Extension for Community Healthcare Outcomes model for primary care providers for the management of alcohol use disorders. Indian J Med Res. 2020 06; 151(6):609-612. PMID: 32719236; PMCID: PMC7602922; DOI: 10.4103/ijmr.IJMR_1851_18;
  10. Madden EF, Kalishman S, Zurawski A, O'Sullivan P, Arora S, Komaromy M. Strategies Used by Interprofessional Teams to Counter Healthcare Marginalization and Engage Complex Patients. Qual Health Res. 2020 06; 30(7):1058-1071. PMID: 32141379
Showing 10 of 36 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 36 publications over 18 distinct years, with a maximum of 5 publications in 2020 and 2021


Recent (within 3 months)

Justice department accuses sober home operator of sexual harassment

The Boston Globe 8/12/2021

Drug Overdose Deaths Hit Alarming Record in 2020

CBS Evening News 7/14/2021

Mandatory Reporting Law Is Harmful for Pregnant People with Substance Use Disorder

HealthCity 6/29/2021


Cultural Competency Still Elusive Among Addiction Medicine Providers

Modern Healthcare 6/10/2021

New Buprenorphine Prescribing Guidelines Won't Solve the Opioid Crisis

HealthCity 5/20/2021

Opioid deaths rose 5 percent in Massachusetts last year

The Boston Globe 5/13/2021

Mass. Hit New Overdose Peak in 2020

WBUR 5/12/2021

Biden administration eases restrictions on prescribing treatment for opioid addiction

The Washington Post 4/27/2021

Homeless people exposed to coronavirus were put in hotels. For hospitals, the move paid off

Los Angeles Times 3/2/2021

Lesson Learned from BMC's COVID-19 Recuperation Unit for Patients Experiencing Homelessness

HealthCity 2/11/2021

The Hardest-Hit: How Nonprofits Rise To the Challenge of COVID-19

Diversity Inc 1/29/2021

Breaking Down the Changes to Prescribing Buprenorphine for Opioid Use Disorder

HealthCity 1/20/2021

Combination of two drugs can help treat methamphetamine addiction for some, new clinical trial data shows

STAT 1/13/2021

21 Ways to Change Your Life

Boston Magazine 11/9/2020

Under the cover of COVID-19 news, the epidemic of opioid overdoses silently surges

Becker's Hospital Review 10/30/2020

Waltham resident named Addiction Nursing Fellow

Wicked Local Waltham: 10/26/2020

Nurse-Led Addiction Fellowship Begins at Boston Medical Center

HealthCity 9/28/2020

Opioid epidemic poised to worsen with ‘tidal wave of new stressors’ amid coronavirus pandemic, experts warn

The Boston Herald 9/22/2020

Activists keep spotlight on drug consumption sites

Sentinel Enterprise 7/30/2020

Access to Opioid Addiction Treatment Opens Up in COVID-19 Crisis

Daily Nurse 6/8/2020

In Boston, a Reopened Hospital Building Houses Infected and Vulnerable

Dig Boston 4/27/2020

Coronavirus Crisis Spurs Access To Online Treatment For Opioid Addiction

NPR 4/20/2020

BMC Reopens Building Sold to State to Provide Continuum of Care for Homeless COVID Patients

HealthCity 4/14/2020

Wasted Time: How San Francisco Failed Its Homeless Population Amid Coronavirus

The Guardian 4/8/2020

Homeless People Need Shelter. Hotels Are Empty. Why Aren’t Cities Acting?

Vice 4/3/2020

Experts: Homeless Population Vulnerable to Coronavirus

Boston 25 News 3/18/2020

City Plans Pop-Up Clinics for Treatment of Homeless Amid Coronavirus Outbreak

The Boston Globe 3/17/2020

Meth Use, Addiction on Rise in Cape

Cape Cod Times 1/30/2020

Expert Opinion: What to Expect From the Opioid Epidemic in the Next 5 Years in Boston

Boston.com 1/7/2020

Across New England are Families Who Have Lost Loved Ones to Opioids. These 4 Parents Lost More Than One Child

Boston.com 12/20/2019

ECHO Institute Leader Hired at Boston Medical Center

Addiction Professional 8/20/2019

I enjoy mentorship and have mentored many researchers and educators at my own and other institutions. I particularly enjoy cross-disciplinary mentorship roles. I am available to provide work/life integration mentorship, and support around parenting, particulary to LGBTQ faculty. Please contact me at Miriam.Komaromy@bmc.org

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Diversity Mentor
  • Project Mentor
  • Research / Scholarly Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')
Komaromy's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department